05/28/2025 11:00
Pimicotinib Demonstrates Best-in-Class Potential with Significant Efficacy and Clinically Meaningful Improvements in Patients with Tenosynovial Giant Cell Tumor

Merck, a leading science and technology company, today announced the presentation of detailed positive results from Part 1 of the global Phase 3 MANEUVER trial evaluating pimicotinib, a potentially best-in-class investigational colony stimulating factor-1 receptor (CSF-1R) inhibitor in development by Abbisko Therapeutics Co., Ltd., in the treatment of patients with tenosynovial giant cell tumor (TGCT). Once-daily pimicotinib demonstrated a statistically significant improvement in the primary en...

06/03/2025 07:00
Manhattan Associates Transforms Enterprise Selling with Enterprise Promise & Fulfill™

Manhattan Associates Inc. (NASDAQ: MANH), the global leader in supply chain commerce solutions, today announced the launch of Enterprise Promise & Fulfill™, a breakthrough cloud-native solution that transforms traditional order management by augmenting existing ERP systems with advanced capabilities to maximise inventory visibility, intelligent order promising, and fulfilment optimisation. Focusing on enhancing a customer’s existing ERP landscape, this solution is positioned to solve a numb...

06/03/2025 07:00
GigaDevice Anchors Global Headquarters in Singapore to Power Synergy and Impact

GigaDevice, a leading semiconductor company specializing in Flash memory, 32-bit microcontrollers (MCUs), sensors, and analog products, today officially opened its global headquarters in Singapore. This strategic move marks a major milestone in GigaDevice’s international growth journey, underscoring its commitment to closer customer engagement, building a resilient and agile supply chain, and strengthening its ecosystem and brand presence across key global markets. Founded in 2005, GigaDevice...